Chronic Familial Neutropenia
Symptoms, Doctors, Treatments, Advances & More

Chronic Familial Neutropenia Overview

Save information for later
Sign Up

Learn About Chronic Familial Neutropenia

What is the definition of Chronic Familial Neutropenia?
Chronic familial neutropenia is a genetic disorder characterized by persistent, lower than normal levels of neutrophils in the blood. Neutrophils are a type of white blood cell that heal infections and repair damaged tissue.
What are the symptoms of Chronic Familial Neutropenia?
Symptoms of chronic familial neutropenia include inflamed gums (gingivitis), periodontitis (gum disease), recurrent oral ulcerations, early tooth loss, and clubbing of fingers.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Chronic Familial Neutropenia?
While chronic familial neutropenia cannot be cured, treatment is focused on alleviating symptoms. Antibiotics or corticosteroids may be used to fight infection. In some select cases, granulocyte-colony stimulating factors or bone marrow transplant may be used.
Who are the top Chronic Familial Neutropenia Local Doctors?
Distinguished in Chronic Familial Neutropenia
Dr. Terrence P. Cescon
Hematology | Oncology | Internal Medicine
Distinguished in Chronic Familial Neutropenia
Dr. Terrence P. Cescon
Hematology | Oncology | Internal Medicine
Referral may be required

McGlinn Cancer Institute - Reading Hospital

420 S 5th Ave, Bldg N, 
West Reading, PA 
484-628-0900
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Terrence Cescon is a Hematologist and an Internal Medicine provider practicing medicine in West Reading, Pennsylvania. Dr. Cescon is rated as a Distinguished provider by MediFind in the treatment of Chronic Familial Neutropenia. He is also highly rated in 76 other conditions, according to our data. His clinical expertise encompasses Acquired Agranulocytosis, Chronic Lymphocytic Leukemia (CLL), Richter Syndrome, Colorectal Cancer, and Prostatectomy. Dr. Cescon is board certified in American Board Of Internal Medicine.

Advanced in Chronic Familial Neutropenia
Dr. Le Wang
Hematology | Oncology | Internal Medicine
Advanced in Chronic Familial Neutropenia
Dr. Le Wang
Hematology | Oncology | Internal Medicine
Referral may be required

McGlinn Cancer Institute - Reading Hospital, Phoenixville Campus

824 Main Street, Ste 101, 
Phoenixville, PA 
610-983-1800
Languages Spoken:
English
See accepted insurances

Le Wang is a Hematologist and an Internal Medicine provider practicing medicine in Phoenixville, Pennsylvania. Dr. Wang is rated as an Advanced provider by MediFind in the treatment of Chronic Familial Neutropenia. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Anemia, Idiopathic Neutropenia, Thrombocytopenia, and Agranulocytosis. Dr. Wang is board certified in American Board Of Internal Medicine.

 
 
 
 
Learn about our expert tiers
Learn More
Advanced in Chronic Familial Neutropenia
Advanced in Chronic Familial Neutropenia
Referral may be required

Vince Lombardi Cancer Clinic

2845 Greenbrier Rd, Ste 250, 
Green Bay, WI 
920-288-4180
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Demet Yasar is a Hematologist practicing medicine in Green Bay, Wisconsin. Dr. Yasar is rated as an Advanced provider by MediFind in the treatment of Chronic Familial Neutropenia. She is also highly rated in 51 other conditions, according to our data. Her clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Pleuropulmonary Blastoma, and Myelodysplastic Syndrome (MDS). Dr. Yasar is board certified in American Board Of Internal Medicine, Hematology.

View All Doctors
What are the latest Chronic Familial Neutropenia Clinical Trials?
A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
Enrollment Status: Recruiting
Publish Date: June 05, 2026
Intervention Type: Drug
Study Phase: Phase 3

Summary: The purpose of this study is to demonstrate the efficacy and evaluate the safety and tolerability of mavorixafor in participants with congenital or acquired primary autoimmune and idiopathic chronic neutropenic disorders who are experiencing recurrent and/or serious infections as assessed by demonstrating its clinical benefit and increasing levels of circulating neutrophils.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Evaluation of the Diagnostic/Therapeutic Course of Patients With Autoimmune Cytopenias (Autoimmune Hemolytic Anemia AIHA, Immune Thrombocytopenia ITP, Chronic Idiopathic/Autoimmune Neutropenia CIN/AIN) and Identification of Predictive and Prognostic Markers.
Evaluation of the Diagnostic/Therapeutic Course of Patients With Autoimmune Cytopenias (Autoimmune Hemolytic Anemia AIHA, Immune Thrombocytopenia ITP, Chronic Idiopathic/Autoimmune Neutropenia CIN/AIN) and Identification of Predictive and Prognostic Markers.
Enrollment Status: Recruiting
Publish Date: October 15, 2024
Intervention Type: Biological, Drug

Summary: The goal of this observational study is to characterize the diagnostic and therapeutic management of autoimmune cytopenias including autoimmune hemolytic anemia, immune thrombocytopenia, and chronic idiopathic/autoimmune neutropenia. The main aims to answer are: * evaluation of traditional and novel diagnostic tools including immunohematology, cytokine essays, bone marrow studies, molecular findin...

View All Clinical Trials